Advances in Nuclear Medicine and Molecular Imaging

Dear Colleagues,

This Special Issue highlights the latest breakthroughs in nuclear medicine and molecular imaging, showcasing cutting-edge technologies and their transformative impact on diagnostics and therapeutics. Key advancements include the development of novel radiotracers that enhance the precision of imaging modalities, such as PET and SPECT, enabling earlier and more accurate detection of diseases, such as cancer, cardiovascular disorders, and neurodegenerative conditions. The integration of artificial intelligence and machine learning into imaging analysis is also explored, offering improved data interpretation and personalized treatment planning. Additionally, this Special Issue delves into theranostics, a rapidly growing field that combines diagnostic imaging with targeted radionuclide therapy, revolutionizing patient care by tailoring treatments to individual molecular profiles. Contributions from leading experts emphasize the interdisciplinary nature of these innovations, bridging radiology, oncology, and computational sciences. This collection not only underscores the current state of the field but also envisions future directions, emphasizing the potential of nuclear medicine and molecular imaging to redefine precision medicine and improve clinical outcomes globally.

Dr. Gabriele Masselli
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.